The duration of action of non-β2-adrenoceptor mediated responses to salmeterol

British Journal of Pharmacology

Volumn 120, Issue 5, 1997, Pages 961-967

  Niais, A T ^a   Coleman, R A ^a   Johnson, M ^b   Vardey, C J ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Pharmagene Laboratories Ltd   (United Kingdom)

Author keywords

Duration of action; Guinea pig gastric fundus; Guinea pig trachea; Human neutrophils; Non adrenoceptor; Salmeterol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; OXYGEN; PROPRANOLOL; SALMETEROL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENCY; GUINEA PIG; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; STOMACH FUNDUS; TRACHEA;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALBUTEROL; ALPRENOLOL; ANIMALS; ELECTRIC STIMULATION; GASTRIC FUNDUS; GUINEA PIGS; HUMANS; MALE; NEUTROPHILS; RECEPTORS, ADRENERGIC, BETA-2; SUPEROXIDES; TRACHEA;

EID: 0030903234     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700986     Document Type: Article

References (26)

1. ANDERSON, O.P. (1992). Molecular pharmacology of formoterol. In Formaterai: Fast and Long-Lasting Bronchodilatation, éd. Holgate, S.T. pp. 3-11. Royal Society of Medicine Services International Congress and Symposium Series, 194.
2. ANDERSON, O.P., LINDEN, A. & RABE, K.F. (1994). Why are longacting /?-adrenoceptor agonists long-acting? Ear. Resp. J., 7, 569-578.
3. APPERLEY, E., HUMPHREY, P.P.A. & LEVY, O.P. (1976). Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br. J. Pharmacol., 58, 211 -221.
4. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 2858.
5. BAKER, A.J. & FULLER, R.W. (1990). Anti-inflammatory effect of salmeterol on human alveolar macrophages. Am. Rev. Resp. Dis., 141, A394.
6. BALL, D.I., BRITTAIN, R.T., COLEMAN, R.A., DENYER, L.H., JACK, D., JOHNSON, M., LUNTS, L.H.C., NIALS, A.T., SHELDRICK, K.E. & SKIDMORE, I.F. (1991). Salmeterol, a novel, long-acting ß2adrenoceptor agonist: Characterization of pharmacological activity in vitro and in vivo. Br. J. Pharmacol., 104, 665-671.
7. BARKER, R.C., COLEMAN, R.A., DAHL, M.R., NIALS, A.T. & ' VARDEY, C.J. (1992). Do salmeterol and formoterol possess agonist activity at atypical /î-adrenoceptors in guinea-pig gastric fundus? Br. J. Pharmacol., 106, 87P.
8. BERGENDAL, A., LINDEN, A., LOTVALL, J., SKOOGH, B.-E. & LOFDAHL, C.-G. (1992). Inhibitory effects of formoterol, salmeterol and salbutamol on nerve-induced contractions in the ferret trachea. Am. Rev. Resp. Dis., 145, A393.
9. BLUE, D.R., BOND, R.A., ADHAM, N., DELMONDO, R., MICHEL, A.D., HOLEN, R.M., WHITING R.L. & CLARKE, D.E. (1990). Antagonist characterizations of atypical /J-adrenoceptors in guinea-pig ileum. Blockade by alprenolol and dihydroalprenolol. J. Pharmacol. Exp. Ther., 252, 1034-1042.
10. BRADSHAW, J., BRITTAIN, R.T., COLEMAN, R.A., JACK, D., KENNEDY, I., LUNTS, L.H.C. & SKIDMORE, I.F. (1987). The design of salmeterol, a long-acting, selective, /J2-adrenoceptor agonist. Br. J. Pharmacol., 92, 590P.
11. BUTCHERS, P.R., VARDEY, C.J. & JOHNSON, M. (1991). Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br. J. Pharmacol., 104, 672-676.
12. COBURN, R.F. & TOMITA, T. (1973). Evidence for noradrenergic inhibitory nerves in the guinea-pig trachealis muscle. Am. J. Physiol.,222, 1072-1080.
13. COLEMAN, R.A., DENYER, L.H. & SHELDRICK, K.E. (1987). ßAdrenoceptors in guinea-pig gastric fundus - are they the same as 'atypical' β-adrenoceptors in rat adipocytes? Br. J. Pharmacol., 90, 40P.
14. COLEMAN, R.A. & NIALS, A.T. (1989). Novel and versatile superfusion system: its use in the evaluation of some spasmogenic and spasmolytic agents using guinea-pig isolated trachéal smooth muscle. J. Pharmacol. Methods, 21, 71-86.
15. COLEMAN, R.A., NIALS, A.T., JOHNSON, M. & VARDEY, C.J. (1994). (S)-Salmeterol: Duration of β- and non-æ-adrenoceptor mediated responses in guinea-pig trachea. Am. Rev. Resp. Dis., 149, A484.
16. IJZERMAN, A.P., NAGESSER, A. & GARRITSEN, A. (1987). The membrane stabilising activity of β-adrenoceptor ligands. Biochem. Pharmacol., 36, 4239-4244.
17. JOHNSON, M., BUTCHERS, P.R., COLEMAN, R.A., NIALS, A.T., STRONG, P., SUMNER, M.J., VARDEY, C.J. & WHELAN, C.J. (1993). The pharmacology of salmeterol. Life Sei., 52, 2131-2143.
18. NIALS, A.T., BARKER, R.C., COLEMAN, R.A. & VARDEY, C.J. (1994a). Are all effects of salmeterol long-lasting? Am. Rev. Resp. Dis., 149, A482.
19. NIALS, A.T. & COLEMAN, R.A. (1988). The interaction between salmeterol and ß-adrenoceptor blocking drugs on guinea-pig isolated trachea. Br. J. Pharmacol., 95, 540P.
20. NIALS, A.T., COLEMAN, R.A., JOHNSON, M. & VARDEY, C.J. (1994b). The /3-adrenoceptor pharmacology of the enantiomers of salmeterol. Am. Rev. Resp. Dis., 149, A481.
21. NIALS, A.T., SUMNER, M.J., JOHNSON, M. & COLEMAN, R.A. (1993). Investigations into factors determining the duration of action of the /?2-adrenoceptor agonist, salmeterol. Br. J. Pharmacol., 108, 507-515.
22. RHODES, D.G., NEWTON, R., BUTLER, R. & HERBETTE, L. (1992). Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers. Mol. Pharmacol., 42, 596-602.
23. STANDIFER, K.M., PITHA, J. & BAKER, S.P. (1989). Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparently irreversible receptor binding and activation of adenylate cyclase activity in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol., 339, 129- 137.
24. SWALES, N. & PATERSON, G. (1990). The actions of salmeterol and two non-selective /î-adrenoceptor agonists, isoxsuprine and nylidrin on ß\- and /?2-adrenoceptors. Br. J. Pharmacol., 100, 489P.
25. VARDEY, C.J., NIALS, A.T. & COLEMAN, R.A. (1994). Inhibitory effects of salmeterol in human neutrophils are short-lasting. Am. Rev. Resp. Dis., 149, A361.
26. WHEELDON, A. & VARDEY, C.J. (1993). Characterization of the inhibitory prostanoid receptors on human neutrophils. Br. J. Pharmacol., 108, 1051-1054.